Baudax Bio, Inc. Quarterly Operating Income (Loss) in USD from Q3 2018 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Baudax Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2018 to Q3 2023.
  • Baudax Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$1.78M, a 50.3% increase year-over-year.
  • Baudax Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$16.4M, a 293% decline year-over-year.
  • Baudax Bio, Inc. annual Operating Income (Loss) for 2022 was -$17.9M, a 29.8% increase from 2021.
  • Baudax Bio, Inc. annual Operating Income (Loss) for 2021 was -$25.5M, a 65.9% increase from 2020.
  • Baudax Bio, Inc. annual Operating Income (Loss) for 2020 was -$74.8M, a 130% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$16.4M -$1.78M +$1.8M +50.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$18.2M -$7.05M -$3.27M -86.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-16
Q1 2023 -$15M -$4.69M +$2.94M +38.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$17.9M -$2.93M -$26.4M -112% Oct 1, 2022 Dec 31, 2022 8-K 2023-06-28
Q3 2022 $8.53M -$3.58M +$12.8M +78.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$4.28M -$3.78M +$12.5M +76.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-16
Q1 2022 -$16.8M -$7.62M +$8.7M +53.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$25.5M $23.5M +$15.5M +192% Oct 1, 2021 Dec 31, 2021 8-K 2023-06-28
Q3 2021 -$41M -$16.4M -$4.12M -33.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$36.9M -$16.3M +$13.9M +46% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$50.8M -$16.3M +$24M +59.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$74.8M $8.04M +$15.4M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-16
Q3 2020 -$90.2M -$12.3M -$1.98M -19.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$88.2M -$30.2M -$19.7M -186% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$68.6M -$40.3M -$36M -838% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$32.5M -$7.37M Oct 1, 2019 Dec 31, 2019 10-K 2021-02-16
Q3 2019 -$10.3M +$8.78M +46.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$10.6M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$4.3M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q3 2018 -$19.1M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.